World's Best Scientists 2026 revealed!
Drug Delivery and Translational Research
H-index 34

Drug Delivery and Translational Research

2190-393X

Published by: Springer

https://www.springer.com/journal/13346

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Chemistry 321 65 106 24
Medicine 1600 39 57 16

Additional Metrics

Number of Best Scientists*: 235
Documents by Best Scientists*: 273
Top 100 Ranked Scientists*: 10
SCIMAGO H-index: 71
SCIMAGO SJR: 1.175
Impact Factor: 5.5

Overview

Top Research Topics at Drug Delivery and Translational Research?

The topics of Drug delivery, Pharmacology, In vivo, Drug and Chromatography are the focal point of discussions in Drug Delivery and Translational Research. The discussions emphasized the topic of Drug delivery in an attempt to further explore the field of Nanotechnology. Pharmacology research featured in the journal incorporates concerns from various other topics such as Liposome, Toxicity and Biodistribution.

The studies on In vivo discussed can also contribute to research in the domains of Biophysics and In vitro. The journal focuses on Chromatography but the discussions also offer insight into other areas such as Pulmonary surfactant, Permeation, Zeta potential and Particle size. The journal focused on Bioavailability research but expanded to cover Solubility.

Most of the Solubility studies addressed also intersect with Dissolution.

  • Drug delivery (30.26%)
  • Pharmacology (25.85%)
  • In vivo (20.58%)

What are the most cited papers published in the journal?

  • Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review. (255 citations)
  • Influence of cholesterol on liposome stability and on in vitro drug release (251 citations)
  • Questioning the use of PEGylation for drug delivery (168 citations)

Research areas of the most cited articles at Drug Delivery and Translational Research:

The journal papers investigate areas of study like Drug delivery, Pharmacology, Nanotechnology, Drug and In vivo. The journal articles with studies in Drug delivery featured incorporate elements of Cancer research, Surgery and Blood–brain barrier. The study of Pharmacology in the published papers encompasses disciplines such as In vitro, as well as fields such as Cholesterol and Neovascularization, all of which overlap with one another.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Enzyme
  • Cancer

The previous edition focused in particular on these issues:

Drug Delivery and Translational Research is organized to address concerns in the fields of Drug delivery, In vivo, Pharmacology, Drug and Bioavailability. Drug delivery research discussed in Drug Delivery and Translational Research aim to provide more information in the subject of Nanotechnology. Chromatography, In vitro, Cytotoxicity and Cancer research are some topics wherein In vivo research discussed in the journal have an impact.

The study of Chromatography encompasses disciplines such as Permeation, as well as fields such as Particle size, all of which overlap with one another. The Pharmacology works featured in Drug Delivery and Translational Research incorporate elements from Self-healing hydrogels and PLGA. Topics in Bioavailability were tackled in line with various other fields like Pharmacokinetics and Solubility.

The most cited articles from the last journal are:

  • Nanotechnology-based antiviral therapeutics. (45 citations)
  • Enhancement strategies for transdermal drug delivery systems: current trends and applications. (16 citations)
  • Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine. (15 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Drug Delivery and Translational Research (based on the number of publications) are:

  • Ryan F. Donnelly (14 papers) published 5 papers at the last edition, 4 more than at the previous edition,
  • Shubhini A. Saraf (13 papers) published 1 paper at the last edition,
  • Zhonggui He (12 papers) published 2 papers at the last edition,
  • María J. Alonso (12 papers) published 6 papers at the last edition, 2 more than at the previous edition,
  • Vandana B. Patravale (11 papers) published 1 paper at the last edition, 2 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Drug Delivery and Translational Research (based on the number of publications) are:

  • Shenyang Pharmaceutical University (28 papers) published 6 papers at the last edition, 4 more than at the previous edition,
  • Queen's University Belfast (24 papers) published 8 papers at the last edition, 6 more than at the previous edition,
  • University of Texas at Austin (16 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • University of Santiago de Compostela (14 papers) published 8 papers at the last edition, 4 more than at the previous edition,
  • Babasaheb Bhimrao Ambedkar University (13 papers) published 1 paper at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.16% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 15.44% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.56% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.37% of all publications and 60.62% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Challenges in nanomedicine clinical translation.

    Josbert M Metselaar;Twan Lammers

    (2020)
    216 Citations
  • Ultrasound-responsive polymer-based drug delivery systems

    Ping Wei;Erik Jan Cornel;Jianzhong Du

    (2021)
    156 Citations
  • Clinical translation of gold nanoparticles

    (2022)
    119 Citations
  • Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.

    Lara Milane;Mansoor Amiji

    (2021)
    89 Citations
  • Methylene blue-loaded niosome: preparation, physicochemical characterization, and in vivo wound healing assessment

    Ali Farmoudeh;Jafar Akbari;Majid Saeedi;Maryam Ghasemi

    (2020)
    81 Citations
  • Evaluation of the clinical impact of repeat application of hydrogel-forming microneedle array patches

    (2020)
    78 Citations
  • Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies

    Ana Cláudia Santos;Diana Costa;Laura Ferreira;Catarina Guerra

    (2021)
    58 Citations
  • An overview of chitosan and its application in infectious diseases

    (2021)
    57 Citations
  • Nanotechnology-based approaches applied to nutraceuticals.

    Akanksha R Singh;Prasanna Kumar Desu;Ramya Krishna Nakkala;Vanitha Kondi

    (2021)
    54 Citations
  • Recent advances in nanocarriers for nutrient delivery

    Srividya Gorantla;Geetika Wadhwa;Shailja Jain;Shridula Sankar

    (2021)
    45 Citations

Related Online Degrees & Career Pathways

For students considering Medicine in the USA, exploring related online degrees can broaden career opportunities and provide flexible education options. One popular alternative is pursuing a bachelors in healthcare administration, which prepares graduates for leadership roles in healthcare settings without the requirement of medical school.

Nursing is another vital pathway in healthcare. Aspiring advanced practice nurses can find quality options through affordable fnp programs that offer flexible schedules for becoming a Family Nurse Practitioner (FNP). For those just starting, affordable foundational courses are available via cheapest online nursing prerequisites, making this career path more accessible.

For registered nurses aiming to advance their qualifications, completing a most affordable bsn to dnp programs online can lead to higher clinical authority and specialized roles. These programs combine convenience with cost-effectiveness, supporting career growth without the need for relocation.

Overall, these alternative and complementary online degrees provide valuable routes within the healthcare field, accommodating diverse interests and schedules while addressing the growing demand for skilled medical professionals.

Best Scientists Contributing to This Journal

Recently Published Articles